Herantis Pharma Oyj Statistics
Total Valuation
Herantis Pharma Oyj has a market cap or net worth of EUR 29.94 million. The enterprise value is 26.48 million.
Market Cap | 29.94M |
Enterprise Value | 26.48M |
Important Dates
The next estimated earnings date is Friday, September 13, 2024.
Earnings Date | Sep 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Herantis Pharma Oyj has 20.16 million shares outstanding. The number of shares has increased by 10.24% in one year.
Shares Outstanding | 20.16M |
Shares Change (YoY) | +10.24% |
Shares Change (QoQ) | +15.35% |
Owned by Insiders (%) | 9.98% |
Owned by Institutions (%) | 58.13% |
Float | 14.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 14.68 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -43.26 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 1.47.
Current Ratio | 2.30 |
Quick Ratio | 2.28 |
Debt / Equity | 1.47 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -661.79% and return on invested capital (ROIC) is -5.09%.
Return on Equity (ROE) | -661.79% |
Return on Assets (ROA) | -2.75% |
Return on Capital (ROIC) | -5.09% |
Revenue Per Employee | n/a |
Profits Per Employee | -55,651 |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.60% in the last 52 weeks. The beta is 0.35, so Herantis Pharma Oyj's price volatility has been lower than the market average.
Beta (5Y) | 0.35 |
52-Week Price Change | -6.60% |
50-Day Moving Average | 1.53 |
200-Day Moving Average | 1.51 |
Relative Strength Index (RSI) | 47.15 |
Average Volume (20 Days) | 6,651 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -193,631 |
Pretax Income | -612,160 |
Net Income | -612,160 |
EBITDA | n/a |
EBIT | -193,631 |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 3.49 million in cash and 30,000 in debt, giving a net cash position of 3.46 million or 0.17 per share.
Cash & Cash Equivalents | 3.49M |
Total Debt | 30,000 |
Net Cash | 3.46M |
Net Cash Per Share | 0.17 |
Equity (Book Value) | 2.04M |
Book Value Per Share | 0.10 |
Working Capital | 2.07M |
Cash Flow
Operating Cash Flow | -5.95M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Herantis Pharma Oyj does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.24% |
Shareholder Yield | -10.24% |
Earnings Yield | -2.19% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |